Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_19850 | 21 | 0.44 | Mlig455_016817 | Neo: - |
GUCY1B1 | Mlig455_016817 {REF} {Length: 2782} {Pfam: Heme NO binding associated [PF07701.16, score=218.0]; Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=199.9]; Haem-NO-binding [PF07700.17, score=175.1]} {Human: ENSG00000061918, GUCY1B1, guanylate cyclase 1 soluble subunit beta 1, [Score=338, Expect=4e-107]} {Mouse: ENSMUSG00000028005, Gucy1b1, guanylate cyclase 1, soluble, beta 1, [Score=342, Expect=6e-109]; ENSMUSG00000021933, Gucy1b2, guanylate cyclase 1, soluble, beta 2, [Score=339, Expect=1e-105]} {Dmel: FBgn0038295, Gyc88E, Guanylyl cyclase at 88E, [RH, Score=593, Expect=0.0]} {Celegans: WBGene00001551, gcy-31, Soluble guanylate cyclase gcy-31, [RH, Score=513, Expect=2e-174]} {Smed: dd_Smed_v6_18111_0_1, dd_Smed_v6_18111_0_1, [RH, Score=823, Expect=0.0]} {RNA1509_55074} {RNA1310_24262} {RNA815_41754} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.532 | 0.911 | 1.00000 | 1.00000 | |
RegionR2 | 2.432 | 0.911 | 0.48942 | 0.87154 | |
RegionR3 | -0.439 | 0.911 | 1.00000 | 1.00000 | |
RegionR4 | 0.267 | 0.911 | 1.00000 | 1.00000 | |
RegionR5 | -0.13 | 0.911 | 1.00000 | 1.00000 | |
RegionR6 | -0.446 | 0.911 | 1.00000 | 1.00000 | |
RegionR7 | -0.608 | 0.911 | 0.99993 | 1.00000 | |
RegionR8 | -0.544 | 0.911 | 0.99993 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.429 | 0.911 | 0.99996 | 1.00000 | |
RegenerationR2 | 1.985 | 0.911 | 0.54423 | 0.89017 | |
RegenerationR3 | 0.569 | 0.911 | 0.69276 | 0.94547 | |
RegenerationR4 | 2.302 | 0.911 | 0.51797 | 0.87877 | |
RegenerationR5 | 0.985 | 0.911 | 0.54953 | 0.88559 | |
RegenerationR6 | 4.068 | 0.911 | 0.35840 | 0.70313 | |
RegenerationBL | -0.462 | 0.911 | 1.00000 | 1.00000 | |
RegenerationTP | -0.391 | 0.911 | 1.00000 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_19850 | 21 | 0.44 | Mlig455_016817 | Neo: - |
GUCY1B1 | 4 | - | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_016817 {REF} {Length: 2782} {Pfam: Heme NO binding associated [PF07701.16, score=218.0]; Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=199.9]; Haem-NO-binding [PF07700.17, score=175.1]} {Human: ENSG00000061918, GUCY1B1, guanylate cyclase 1 soluble subunit beta 1, [Score=338, Expect=4e-107]} {Mouse: ENSMUSG00000028005, Gucy1b1, guanylate cyclase 1, soluble, beta 1, [Score=342, Expect=6e-109]; ENSMUSG00000021933, Gucy1b2, guanylate cyclase 1, soluble, beta 2, [Score=339, Expect=1e-105]} {Dmel: FBgn0038295, Gyc88E, Guanylyl cyclase at 88E, [RH, Score=593, Expect=0.0]} {Celegans: WBGene00001551, gcy-31, Soluble guanylate cyclase gcy-31, [RH, Score=513, Expect=2e-174]} {Smed: dd_Smed_v6_18111_0_1, dd_Smed_v6_18111_0_1, [RH, Score=823, Expect=0.0]} {RNA1509_55074} {RNA1310_24262} {RNA815_41754} |
2. | MligTC455_12511 | 68 | 1.42 | Mlig455_017662 | Neo: - Age: - |
3.687 | - | - | 0.976 | 0.861 | 0.968 | 0.882 | Mlig455_017662 {REF} {Length: 906} {RNA1310_37507} {RNA815_32171} | |
3. | MligTC455_35773 | 89 | 1.86 | Mlig455_064449, Mlig455_064456 | Neo: - Age: - Region-enriched R2: 5.198/0.00725 |
NANP | 3.652 | - | - | 0.950 | 0.921 | 0.845 | 0.936 | Mlig455_064449 {REF} {Length: 503} {NoTransDecoderORF} {RNA1310_53432.2} Mlig455_064456 {REF} {Length: 3122} {Pfam: Haloacid dehalogenase-like hydrolase [PF13419.8, score=56.3]; haloacid dehalogenase-like hydrolase [PF00702.28, score=55.3]; HAD-hyrolase-like [PF13242.8, score=44.6]} {Human: ENSG00000170191, NANP, N-acetylneuraminic acid phosphatase, [RH, Score=47.4, Expect=8e-06]} {Mouse: ENSMUSG00000053916, Nanp, N-acetylneuraminic acid phosphatase, [RH, Score=48.5, Expect=2e-06]} {Celegans: WBGene00018465, F45E1.4, [RH, Score=147, Expect=4e-43]} {Smed: dd_Smed_v6_2813_0_3, dd_Smed_v6_2813_0_3, [Score=174, Expect=2e-50]} {RNA1310_59243} {RNA815_62364} |
4. | MligTC455_43979 | 188 | 3.92 | Mlig455_000082, Mlig455_063749 | Neo: - Age: - |
GHSR | 3.642 | - | - | 0.985 | 0.885 | 0.965 | 0.807 | Mlig455_000082 {REF} {Length: 1342} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=53.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Human: ENSG00000121853, GHSR, growth hormone secretagogue receptor, [Score=52.0, Expect=7e-07]} {Mouse: ENSMUSG00000051136, Ghsr, growth hormone secretagogue receptor, [Score=50.4, Expect=2e-06]} {Celegans: WBGene00018798, gnrr-1, GoNadotropin-Releasing hormone Receptor (GnRHR) related, [Score=48.9, Expect=3e-06]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=160, Expect=9e-47]} {RNA1310_30553} Mlig455_063749 {REF} {Length: 1323} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.4]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=157, Expect=1e-45]} {RNA1310_30553} |
5. | MligTC455_40387 | 28 | 0.59 | Mlig455_019391 | Neo: - Age: Up-Down-Down |
3.633 | - | - | 0.989 | 0.894 | 0.941 | 0.809 | Mlig455_019391 {REF} {Length: 2094} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=34.2]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=146, Expect=1e-37]} {RNA1310_29891} {RNA815_15562} | |
6. | MligTC455_17021 | 49 | 1.02 | Mlig455_030263 | Neo: - Age: - |
3.625 | - | - | 0.992 | 0.865 | 0.982 | 0.786 | Mlig455_030263 {REF} {Length: 566} {TRANSSPLICED} {Pfam: Galactosyltransferase [PF01762.23, score=23.7]} {Dmel: FBgn0000221, brn, brainiac, [Score=45.8, Expect=1e-06]} {RNA1310_35735} {RNA815_59866} | |
7. | MligTC455_37848 | 42 | 0.87 | Mlig455_049400 | Neo: - Age: - |
3.58 | - | - | 0.955 | 0.845 | 0.841 | 0.939 | Mlig455_049400 {REF} {Length: 2374} {RNA1509_58287} {RNA1310_1148.1} {RNA815_900} | |
8. | MligTC455_14293 | 27 | 0.55 | Mlig455_005699 | Neo: - Age: - |
3.553 | - | - | 0.997 | 0.852 | 0.895 | 0.809 | Mlig455_005699 {REF} {Length: 220} {NoTransDecoderORF} {RNA1509_35414} {RNA1310_4580} | |
9. | MligTC455_18269 | 27 | 0.56 | Mlig455_008658 | Neo: - Age: - |
3.536 | - | - | 0.997 | 0.874 | 0.856 | 0.809 | Mlig455_008658 {REF} {Length: 1290} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=19.1]} {RNA1509_25258} {RNA1310_4580, RNA1509_25258} {RNA1509_25258, RNA815_9496.1} | |
10. | MligTC455_40290 | 58 | 1.21 | Mlig455_058728 | Neo: - Age: - Region-enriched R2: 4.464/0.00807 |
3.535 | - | - | 0.956 | 0.777 | 0.848 | 0.954 | Mlig455_058728 {REF} {Length: 1351} {Pfam: CUB domain [PF00431.22, score=48.4]} {RNA1310_48745} {RNA815_23305} | |
11. | MligTC455_46188 | 25 | 0.51 | Mlig455_039664, Mlig455_039727 | Neo: - Age: - |
3.53 | - | - | 0.975 | 0.861 | 0.885 | 0.809 | Mlig455_039664 {REF} {Length: 1353} Mlig455_039727 {REF} {Length: 1348} |
|
12. | MligTC455_12512 | 80 | 1.68 | Mlig455_017689 | Neo: - Age: - |
3.523 | - | - | 0.956 | 0.800 | 0.964 | 0.803 | Mlig455_017689 {REF} {Length: 934} {RNA1310_37507} {RNA815_32171} | |
13. | MligTC455_49434 | 157 | 3.26 | Mlig455_068252, Mlig455_068272 | Neo: - Age: - |
3.514 | - | - | 0.954 | 0.849 | 0.965 | 0.746 | Mlig455_068252 {REF} {Length: 718} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.5, Expect=1e-12]} {RNA1310_75052} Mlig455_068272 {REF} {Length: 1055} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.2, Expect=2e-12]} {RNA1310_75052} |
|
14. | MligTC455_10966 | 15 | 0.31 | Mlig455_013154 | Neo: - Age: - |
3.51 | - | - | 0.953 | 0.801 | 0.967 | 0.789 | Mlig455_013154 {REF} {Length: 827} {Pfam: Lectin C-type domain [PF00059.23, score=21.8]} {RNA1509_20946} {RNA1310_65161} {RNA815_4785.1} | |
15. | MligTC455_14873 | 15 | 0.31 | Mlig455_021074 | Neo: - Age: - |
3.508 | - | - | 0.857 | 0.882 | 0.967 | 0.802 | Mlig455_021074 {REF} {Length: 1075} {Pfam: WSC domain [PF01822.21, score=52.6]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=46.6, Expect=8e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=50.8, Expect=2e-07]} {RNA1310_33352.1} {RNA815_14158.1} | |
16. | MligTC455_31663 | 23 | 0.48 | Mlig455_013845 | Neo: - Age: - |
3.503 | - | - | 0.956 | 0.851 | 0.946 | 0.750 | Mlig455_013845 {REF} {Length: 1056} {RNA1310_32319} {RNA815_18072} | |
17. | MligTC455_28693 | 60 | 1.26 | Mlig455_022354 | Neo: - Age: - |
3.484 | - | - | 0.971 | 0.880 | 0.827 | 0.806 | Mlig455_022354 {REF} {Length: 816} {Pfam: WSC domain [PF01822.21, score=53.0]; PAN domain [PF00024.28, score=20.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=48.1, Expect=2e-06]} {RNA1509_43359} {RNA1310_59466.1} {RNA815_19988} | |
18. | MligTC455_16526 | 125 | 2.61 | Mlig455_026747, Mlig455_051738, Mlig455_051739, Mlig455_051760 | Neo: - Age: Up-Down-Down |
GABRG3 | 3.481 | - | - | 0.899 | 0.847 | 0.977 | 0.758 | Mlig455_026747 {REF} {Length: 6317} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=31.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=25.1]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=57.8, Expect=4e-08]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=57.4, Expect=5e-08]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=60.8, Expect=3e-09]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=49.3, Expect=7e-06]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [Score=517, Expect=2e-177]} {RNA1310_24908.1} {RNA815_12627} Mlig455_051738 {REF} {Length: 1364} {RNA1310_43175} {RNA815_39065} Mlig455_051739 {REF} {Length: 2058} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=32.3]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=58.9, Expect=1e-08]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=62.8, Expect=5e-10]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [Score=532, Expect=0.0]} {RNA1310_16047} {RNA815_12627} Mlig455_051760 {REF} {Length: 5962} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=32.2]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=72.8, Expect=5e-13]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=69.7, Expect=5e-12]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=77.0, Expect=2e-14]} {Dmel: FBgn0030707, CG8916, [Score=60.5, Expect=2e-09]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=57.8, Expect=1e-08]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [RH, Score=573, Expect=0.0]} {RNA1310_24908.1} {RNA815_12627} |
19. | MligTC455_14842 | 21 | 0.45 | Mlig455_041074 | Neo: - Age: - |
3.452 | - | - | 0.999 | 0.768 | 0.915 | 0.770 | Mlig455_041074 {REF} {Length: 1383} {RNA1310_60383} {RNA815_48502} | |
20. | MligTC455_18099 | 24 | 0.51 | Mlig455_036525 | Neo: - Age: - |
PPA1 | 3.452 | - | - | 0.955 | 0.769 | 0.920 | 0.808 | Mlig455_036525 {REF} {Length: 1911} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1310_57333.1} {RNA815_22340} |
21. | MligTC455_50123 | 29 | 0.61 | Mlig455_063710 | Neo: - Age: - Region-enriched R4: 5.673/0.02044 |
3.447 | - | - | 0.820 | 0.881 | 0.967 | 0.779 | Mlig455_063710 {REF} {Length: 1119} | |
22. | MligTC455_38279 | 69 | 1.44 | Mlig455_045200 | Neo: - Age: - |
NOL4L | 3.446 | - | - | 0.710 | 0.854 | 0.911 | 0.971 | Mlig455_045200 {REF} {Length: 1997} {Human: ENSG00000197183, NOL4L, nucleolar protein 4 like, [RH, Score=150, Expect=9e-40]} {Mouse: ENSMUSG00000061411, Nol4l, nucleolar protein 4-like, [RH, Score=150, Expect=1e-39]} {Dmel: FBgn0283651, CG46301, [RH, Score=147, Expect=2e-37]} {Smed: dd_Smed_v6_27580_0_1, dd_Smed_v6_27580_0_1, [RH, Score=85.5, Expect=1e-17]} {RNA1310_76365.1} {RNA815_48196} |
23. | MligTC455_32644 | 41 | 0.86 | Mlig455_043770, Mlig455_043786 | Neo: - Age: - Region-enriched R2: 6.705/0.00336 |
3.427 | - | - | 0.998 | 0.797 | 0.828 | 0.804 | Mlig455_043770 {REF} {Length: 1011} {Pfam: PAN domain [PF00024.28, score=19.3]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=60.8, Expect=3e-11]} {RNA1509_35604} {RNA1310_57814} {RNA815_29718} Mlig455_043786 {REF} {Length: 1348} {Pfam: PAN domain [PF00024.28, score=19.3]} {RNA1509_35604} {RNA1310_34182} {RNA815_29718} |
|
24. | MligTC455_16729 | 75 | 1.57 | Mlig455_013762 | Neo: - Age: Up-Down-Down Region-enriched R4: 4.685/0.03582 |
3.426 | - | - | 0.998 | 0.824 | 0.800 | 0.804 | Mlig455_013762 {REF} {Length: 2706} {Pfam: Glycine rich protein [PF12810.9, score=24.7]; PAN domain [PF00024.28, score=18.7]} {RNA1310_22079} {RNA815_24304} | |
25. | MligTC455_17568 | 33 | 0.68 | Mlig455_059349, Mlig455_065584 | Neo: - Age: - |
3.408 | - | - | 0.965 | 0.912 | 0.722 | 0.809 | Mlig455_059349 {REF} {Length: 1132} {RNA1509_24218} {RNA1310_25312.1} {RNA815_12390} Mlig455_065584 {REF} {Length: 1132} {RNA1509_24218} {RNA1310_25312.1} {RNA815_12390} |
|
26. | MligTC455_12180 | 107 | 2.23 | Mlig455_038554, Mlig455_052202, Mlig455_053449 | Neo: - Age: logFC(26M/2M)=-0.655 Region-enriched R2: 5.717/0.01573 |
CNGA3 | 3.389 | - | - | 0.799 | 0.820 | 0.966 | 0.804 | Mlig455_038554 {REF} {Length: 2866} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=75.9]; Cyclic nucleotide-binding domain [PF00027.31, score=69.1]; Ion transport protein [PF00520.33, score=68.6]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [RH, Score=650, Expect=0.0]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [RH, Score=644, Expect=0.0]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [RH, Score=607, Expect=0.0]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [RH, Score=563, Expect=0.0]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [RH, Score=669, Expect=0.0]} {RNA1310_22950} {RNA815_16119} Mlig455_052202 {REF} {Length: 3203} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=76.1]; Cyclic nucleotide-binding domain [PF00027.31, score=69.1]; Ion transport protein [PF00520.33, score=68.2]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [RH, Score=650, Expect=0.0]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [RH, Score=644, Expect=0.0]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [RH, Score=605, Expect=0.0]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [RH, Score=563, Expect=0.0]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [RH, Score=667, Expect=0.0]} {RNA1310_22950} {RNA815_16119} Mlig455_053449 {REF} {Length: 991} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=79.9]; Cyclic nucleotide-binding domain [PF00027.31, score=29.1]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=171, Expect=7e-50]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=161, Expect=2e-46]; ENSMUSG00000067220, Cnga1, cyclic nucleotide gated channel alpha 1, [Score=155, Expect=4e-44]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [Score=148, Expect=1e-41]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=149, Expect=3e-42]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=155, Expect=8e-45]} {RNA1310_61700} {RNA815_16119} |
27. | MligTC455_18891 | 275 | 5.73 | Mlig455_024941 | Neo: - Age: - Region-enriched R2: 2.016/0.02450 |
3.386 | - | - | 0.982 | 0.835 | 0.764 | 0.805 | Mlig455_024941 {REF} {Length: 394} {NoTransDecoderORF} {RNA1509_45136} {RNA1310_56753} {RNA815_28269} | |
28. | MligTC455_24753 | 11 | 0.23 | Mlig455_016700 | Neo: - Age: - |
3.367 | - | - | 0.999 | 0.897 | 0.702 | 0.769 | Mlig455_016700 {REF} {Length: 1032} {Pfam: PAN domain [PF00024.28, score=20.1]} {RNA1310_36328.1} {RNA815_39270} | |
29. | MligTC455_34614 | 24 | 0.5 | Mlig455_060978 | Neo: - Age: - |
3.352 | - | - | 0.969 | 0.832 | 0.750 | 0.801 | Mlig455_060978 {REF} {Length: 1770} {RNA1310_81929} | |
30. | MligTC455_26652 | 30 | 0.63 | Mlig455_036452 | Neo: - Age: - |
NR2E1 | 3.345 | - | - | 0.879 | 0.807 | 0.957 | 0.702 | Mlig455_036452 {REF} {Length: 2848} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=99.9]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=55.3]} {Human: ENSG00000112333, NR2E1, nuclear receptor subfamily 2 group E member 1, [Score=139, Expect=2e-35]} {Mouse: ENSMUSG00000019803, Nr2e1, nuclear receptor subfamily 2, group E, member 1, [Score=139, Expect=1e-35]} {Dmel: FBgn0015381, dsf, dissatisfaction, [Score=129, Expect=6e-31]} {Celegans: WBGene00021417, nhr-236, Nuclear Hormone Receptor family, [RH, Score=135, Expect=1e-35]} {Smed: dd_Smed_v6_25420_0_1, dd_Smed_v6_25420_0_1, [RH, Score=182, Expect=3e-50]} {RNA1310_57853} {RNA815_57699} |
31. | MligTC455_16610 | 98 | 2.05 | Mlig455_069894 | Neo: - Age: - Region-enriched R2: 5.254/0.03136 |
WSCD2 | 3.339 | - | - | 0.957 | 0.720 | 0.867 | 0.795 | Mlig455_069894 {REF} {Length: 827} {Pfam: WSC domain [PF01822.21, score=59.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=55.1, Expect=4e-09]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=9e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.4, Expect=2e-08]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
32. | MligTC455_41226 | 44 | 0.92 | Mlig455_019357, Mlig455_059122 | Neo: - Age: - |
GALNT1 | 3.328 | - | - | 0.951 | 0.816 | 0.826 | 0.735 | Mlig455_019357 {REF} {Length: 1606} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=97.5]; Glycosyltransferase like family 2 [PF13641.8, score=38.9]; N-terminal domain of galactosyltransferase [PF02709.16, score=29.1]; Glycosyltransferase like family 2 [PF10111.11, score=18.5]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=318, Expect=2e-103]; ENSG00000139629, GALNT6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=311, Expect=4e-100]; ENSG00000257594, GALNT4, polypeptide N-acetylgalactosaminyltransferase 4, [Score=305, Expect=3e-98]; ENSG00000259075, POC1B-GALNT4, POC1B-GALNT4 readthrough, [Score=305, Expect=3e-98]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=316, Expect=1e-102]; ENSMUSG00000037280, Galnt6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=308, Expect=9e-99]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=302, Expect=3e-97]} {Dmel: FBgn0050463, CG30463, [Score=345, Expect=5e-113]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=350, Expect=3e-115]} {Smed: dd_Smed_v6_8580_0_1, dd_Smed_v6_8580_0_1, [Score=353, Expect=1e-117]} {RNA1310_25598} {RNA815_36943} Mlig455_059122 {REF} {Length: 2150} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=96.4]; Glycosyltransferase like family 2 [PF13641.8, score=35.9]; N-terminal domain of galactosyltransferase [PF02709.16, score=29.5]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=313, Expect=2e-101]; ENSG00000139629, GALNT6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=307, Expect=2e-98]; ENSG00000257594, GALNT4, polypeptide N-acetylgalactosaminyltransferase 4, [Score=300, Expect=6e-96]; ENSG00000259075, POC1B-GALNT4, POC1B-GALNT4 readthrough, [Score=299, Expect=7e-96]; ENSG00000144278, GALNT13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=298, Expect=1e-95]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=311, Expect=1e-100]; ENSMUSG00000037280, Galnt6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=305, Expect=1e-97]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=298, Expect=8e-96]; ENSMUSG00000026994, Galnt3, polypeptide N-acetylgalactosaminyltransferase 3, [Score=296, Expect=5e-94]; ENSMUSG00000026828, Galnt5, polypeptide N-acetylgalactosaminyltransferase 5, [Score=296, Expect=2e-91]} {Dmel: FBgn0050463, CG30463, [Score=340, Expect=3e-111]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=344, Expect=3e-113]} {Smed: dd_Smed_v6_8580_0_1, dd_Smed_v6_8580_0_1, [Score=350, Expect=3e-116]} {RNA1310_25598} {RNA815_36943} |
33. | MligTC455_35933 | 19 | 0.4 | Mlig455_033271 | Neo: - Age: - |
3.31 | - | - | 1.000 | 0.702 | 0.799 | 0.809 | Mlig455_033271 {REF} {Length: 1256} {RNA1310_22041} {RNA815_26444} | |
34. | MligTC455_19775 | 36 | 0.74 | Mlig455_060359 | Neo: - Age: - |
FCN1 | 3.303 | - | - | 0.969 | 0.868 | 0.716 | 0.750 | Mlig455_060359 {REF} {Length: 1109} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.9]} {Human: ENSG00000085265, FCN1, ficolin 1, [Score=99.0, Expect=2e-23]; ENSG00000142748, FCN3, ficolin 3, [Score=99.0, Expect=1e-23]; ENSG00000160339, FCN2, ficolin 2, [Score=98.2, Expect=2e-23]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=100, Expect=3e-24]} {Dmel: FBgn0034160, CG5550, [Score=97.8, Expect=7e-24]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=90.1, Expect=4e-20]} {RNA1310_67383} {RNA815_45536} |
35. | MligTC455_25242 | 55 | 1.15 | Mlig455_046799, Mlig455_063518 | Neo: - Age: - Region-enriched R2: 5.810/0.00185 |
DOC2B, RPH3A | 3.289 | - | - | 0.987 | 0.783 | 0.771 | 0.748 | Mlig455_046799 {REF} {Length: 1832} {Pfam: C2 domain [PF00168.32, score=147.1]} {Human: ENSG00000272636, DOC2B, double C2 domain beta, [Score=243, Expect=3e-76]; ENSG00000272670, DOC2B, double C2 domain beta, [Score=243, Expect=3e-76]; ENSG00000089169, RPH3A, rabphilin 3A, [Score=237, Expect=3e-71]; ENSG00000149927, DOC2A, double C2 domain alpha, [Score=234, Expect=1e-72]} {Mouse: ENSMUSG00000020848, Doc2b, double C2, beta, [Score=243, Expect=3e-76]; ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=239, Expect=1e-74]; ENSMUSG00000029608, Rph3a, rabphilin 3A, [Score=237, Expect=4e-71]} {Dmel: FBgn0030230, Rph, Rabphilin, [RH, Score=188, Expect=2e-55]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=216, Expect=4e-62]} {Smed: dd_Smed_v6_12977_0_1, dd_Smed_v6_12977_0_1, [Score=239, Expect=5e-73]} {RNA1310_26201} {RNA815_12702} Mlig455_063518 {REF} {Length: 2724} {Pfam: C2 domain [PF00168.32, score=147.7]} {Human: ENSG00000089169, RPH3A, rabphilin 3A, [RH, Score=240, Expect=2e-72]} {Mouse: ENSMUSG00000029608, Rph3a, rabphilin 3A, [RH, Score=240, Expect=2e-72]} {Dmel: FBgn0030230, Rph, Rabphilin, [RH, Score=191, Expect=1e-54]} {Celegans: WBGene00004316, rbf-1, Rabphilin-1, [Score=219, Expect=4e-63]} {Smed: dd_Smed_v6_12977_0_2, dd_Smed_v6_12977_0_2, [Score=241, Expect=1e-73]} {RNA1310_26201} {RNA815_12702} |
36. | MligTC455_05098 | 127 | 2.65 | Mlig455_009525, Mlig455_009531 | Neo: - Age: Up-Down-Down Region-enriched R4: 4.095/0.01821 |
KCNH7 | 3.277 | - | - | 0.959 | 0.816 | 0.760 | 0.742 | Mlig455_009525 {REF} {Length: 2109} {Pfam: Ion transport protein [PF00520.33, score=111.8]; Ion channel [PF07885.18, score=46.1]; Cyclic nucleotide-binding domain [PF00027.31, score=36.3]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=29.8]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=528, Expect=4e-176]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=509, Expect=2e-170]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=505, Expect=9e-167]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=527, Expect=4e-175]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=510, Expect=3e-171]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=504, Expect=9e-167]} {Dmel: FBgn0003353, sei, seizure, [Score=507, Expect=2e-171]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=496, Expect=1e-169]} {Smed: dd_Smed_v6_12978_0_1, dd_Smed_v6_12978_0_1, [Score=608, Expect=0.0]} {RNA1509_56964} {RNA1310_41939} {RNA815_5858.1} Mlig455_009531 {REF} {Length: 3631} {Pfam: Ion transport protein [PF00520.33, score=110.4]; Ion channel [PF07885.18, score=45.2]; Cyclic nucleotide-binding domain [PF00027.31, score=43.3]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=619, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=597, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=596, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=617, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=602, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=596, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=591, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=579, Expect=0.0]} {Smed: dd_Smed_v6_12978_0_4, dd_Smed_v6_12978_0_4, [RH, Score=716, Expect=0.0]} {RNA1509_56964} {RNA1310_23186, RNA1509_56964} {RNA1509_56964, RNA815_5858.2} |
37. | MligTC455_43963 | 1010 | 21.04 | Mlig455_015437 | Neo: - Age: Down-Down-Up Region-enriched R2: 2.083/0.01168 |
3.267 | - | - | 0.963 | 0.737 | 0.815 | 0.752 | Mlig455_015437 {REF} {Length: 612} {RNA1509_32160} {RNA1310_60746, RNA1509_32160} {RNA1509_32160, RNA815_30740} | |
38. | MligTC455_41870 | 67 | 1.39 | Mlig455_042417 | Neo: - Age: Up-Down-Up |
ANGPTL1 | 3.259 | - | - | 0.987 | 0.793 | 0.702 | 0.777 | Mlig455_042417 {REF} {Length: 1469} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=110.4]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=102, Expect=6e-24]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=99.8, Expect=3e-23]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=104, Expect=6e-25]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=99.4, Expect=4e-23]} {Dmel: FBgn0003326, sca, scabrous, [Score=89.4, Expect=1e-19]} {Celegans: WBGene00017013, ensh-1, [Score=55.1, Expect=2e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=73.6, Expect=1e-14]} {RNA1509_28467} {RNA1310_67810} {RNA815_18070.1} |
39. | MligTC455_18586 | 93 | 1.93 | Mlig455_020226 | Neo: - Age: Down-Down-Up |
3.259 | - | - | 0.951 | 0.706 | 0.821 | 0.781 | Mlig455_020226 {REF} {Length: 1261} {RNA1310_64121} {RNA815_32233} | |
40. | MligTC455_32028 | 19 | 0.39 | Mlig455_019343, Mlig455_019346 | Neo: - Age: - |
GRIA2 | 3.249 | - | - | 1.000 | 0.719 | 0.742 | 0.788 | Mlig455_019343 {REF} {Length: 3241} {Pfam: Ligand-gated ion channel [PF00060.28, score=96.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=57.9]; Receptor family ligand binding region [PF01094.30, score=49.1]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.0]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=150, Expect=1e-36]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=149, Expect=2e-36]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=146, Expect=2e-35]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=144, Expect=9e-35]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=144, Expect=1e-34]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=150, Expect=5e-37]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=150, Expect=8e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=145, Expect=3e-35]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=145, Expect=3e-35]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=144, Expect=5e-35]} {Dmel: FBgn0039927, CG11155, [Score=158, Expect=1e-39]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=125, Expect=3e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=250, Expect=2e-75]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.1} Mlig455_019346 {REF} {Length: 519} {Pfam: Receptor family ligand binding region [PF01094.30, score=21.5]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.2} |
41. | MligTC455_46831 | 32 | 0.66 | Mlig455_000140 | Neo: - Age: - |
2.853 | - | - | 0.979 | 0.886 | - | 0.988 | Mlig455_000140 {REF} {Length: 1100} | |
42. | MligTC455_40617 | 11 | 0.22 | Mlig455_043552 | Neo: - Age: - |
WSCD2 | 2.808 | - | - | 0.989 | 0.873 | 0.946 | - | Mlig455_043552 {REF} {Length: 962} {Pfam: WSC domain [PF01822.21, score=54.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=57.8, Expect=3e-09]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=58.2, Expect=1e-09]} |
43. | MligTC455_51178 | 190 | 3.97 | Mlig455_066114 | Neo: - Age: - |
2.794 | - | - | 0.966 | 0.901 | 0.927 | - | Mlig455_066114 {REF} {Length: 2408} {Smed: dd_Smed_v6_70006_0_1, dd_Smed_v6_70006_0_1, [Score=58.5, Expect=4e-10]} {RNA1509_36492} {RNA1310_14560, RNA1509_36492} {RNA1509_36492, RNA815_5366} | |
44. | MligTC455_43714 | 152 | 3.18 | Mlig455_000684, Mlig455_000736 | Neo: - Age: - |
2.784 | - | - | 0.990 | - | 0.985 | 0.809 | Mlig455_000684 {REF} {Length: 796} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} Mlig455_000736 {REF} {Length: 797} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} |
|
45. | MligTC455_10383 | 13 | 0.27 | Mlig455_040199 | Neo: - Age: - |
2.781 | - | - | 0.995 | - | 0.983 | 0.803 | Mlig455_040199 {REF} {Length: 860} {Pfam: Lectin C-type domain [PF00059.23, score=27.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
46. | MligTC455_11306 | 10 | 0.2 | Mlig455_030223 | Neo: - Age: - |
ANGPT4 | 2.772 | - | - | 0.997 | - | 0.967 | 0.808 | Mlig455_030223 {REF} {Length: 1102} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=82.4]} {Human: ENSG00000101280, ANGPT4, angiopoietin 4, [Score=75.5, Expect=4e-15]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=72.8, Expect=2e-14]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=71.6, Expect=6e-14]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=70.5, Expect=1e-13]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=68.9, Expect=6e-13]; ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=68.6, Expect=6e-13]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=68.6, Expect=7e-13]} {Dmel: FBgn0087011, CG41520, [Score=60.8, Expect=2e-10]} {Celegans: WBGene00017013, ensh-1, [Score=46.6, Expect=7e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=61.6, Expect=6e-11]} {RNA1509_28467} {RNA1310_29813.1} {RNA815_57322} |
47. | MligTC455_14795 | 8 | 0.16 | Mlig455_001604 | Neo: - Age: - |
NPR1 | 2.764 | - | - | 0.988 | - | 0.967 | 0.809 | Mlig455_001604 {REF} {Length: 2245} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=181.5]} {Human: ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=251, Expect=3e-71]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=243, Expect=2e-68]} {Mouse: ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-70]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=244, Expect=1e-71]} {Dmel: FBgn0010197, Gyc32E, Guanyl cyclase at 32E, [Score=227, Expect=4e-63]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=224, Expect=2e-62]} {Smed: dd_Smed_v6_7644_0_1, dd_Smed_v6_7644_0_1, [Score=225, Expect=1e-62]} {RNA1310_77875} |
48. | MligTC455_19454 | 11 | 0.23 | Mlig455_034200 | Neo: - Age: - |
KREMEN1 | 2.76 | - | - | 0.991 | - | 0.961 | 0.808 | Mlig455_034200 {REF} {Length: 1253} {Pfam: WSC domain [PF01822.21, score=46.0]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=55.5, Expect=6e-08]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=57.8, Expect=6e-09]} {RNA1310_36702.1} {RNA815_33128} |
49. | MligTC455_33440 | 62 | 1.29 | Mlig455_053806, Mlig455_053807 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.142/0.02950 |
GRID1 | 2.757 | - | - | 0.996 | - | 0.978 | 0.783 | Mlig455_053806 {REF} {Length: 3070} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.7]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=39.8]; Receptor family ligand binding region [PF01094.30, score=28.6]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=145, Expect=2e-35]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=143, Expect=2e-34]} {Dmel: FBgn0038837, CG3822, [Score=126, Expect=2e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=257, Expect=1e-77]} {RNA1310_13880.2} {RNA815_12458} Mlig455_053807 {REF} {Length: 3142} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=38.3]; Receptor family ligand binding region [PF01094.30, score=36.5]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=139, Expect=2e-33]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=137, Expect=1e-32]} {Dmel: FBgn0038837, CG3822, [Score=125, Expect=5e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=117, Expect=1e-26]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=259, Expect=2e-78]} {RNA1310_13880.2} {RNA815_12458} |
50. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
2.755 | - | - | 0.980 | - | 0.966 | 0.809 | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
51. | MligTC455_15344 | 63 | 1.3 | Mlig455_037163, Mlig455_052315 | Neo: - Age: - |
FEV | 2.754 | - | - | 0.985 | 0.839 | - | 0.930 | Mlig455_037163 {REF} {Length: 2044} {Pfam: Ets-domain [PF00178.24, score=118.9]} {Human: ENSG00000163497, FEV, FEV, ETS transcription factor, [RH, Score=186, Expect=7e-58]} {Mouse: ENSMUSG00000055197, Fev, FEV (ETS oncogene family), [RH, Score=187, Expect=4e-58]} {Dmel: FBgn0005658, Ets65A, Ets at 65A, [Score=206, Expect=2e-65]} {Celegans: WBGene00020368, ast-1, Axon STeering defect, [RH, Score=196, Expect=2e-60]} {Smed: dd_Smed_v6_11113_0_1, dd_Smed_v6_11113_0_1, [Score=226, Expect=3e-72]} {RNA1509_29423} {RNA1310_30786.1} {RNA815_45406} Mlig455_052315 {REF} {Length: 2061} {Pfam: Ets-domain [PF00178.24, score=118.7]; Protein of unknown function (DUF2722) [PF10846.10, score=18.2]} {Human: ENSG00000163497, FEV, FEV, ETS transcription factor, [RH, Score=186, Expect=2e-57]} {Mouse: ENSMUSG00000055197, Fev, FEV (ETS oncogene family), [RH, Score=186, Expect=1e-57]} {Dmel: FBgn0005658, Ets65A, Ets at 65A, [Score=207, Expect=2e-65]} {Celegans: WBGene00020368, ast-1, Axon STeering defect, [RH, Score=196, Expect=4e-60]} {Smed: dd_Smed_v6_14611_0_1, dd_Smed_v6_14611_0_1, [RH, Score=211, Expect=7e-65]} {RNA1509_29423} {RNA1310_30786.1} {RNA815_45406} |
52. | MligTC455_43581 | 177 | 3.68 | Mlig455_042725, Mlig455_042827, Mlig455_063146 | Neo: - Age: Up-Down-Down |
GRIA2 | 2.746 | - | - | 0.974 | 0.856 | - | 0.916 | Mlig455_042725 {REF} {Length: 3074} {Pfam: Ligand-gated ion channel [PF00060.28, score=104.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.7]; Receptor family ligand binding region [PF01094.30, score=33.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.7]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=153, Expect=1e-37]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=149, Expect=2e-36]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=147, Expect=7e-36]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=152, Expect=2e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=148, Expect=3e-36]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=147, Expect=8e-36]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=145, Expect=2e-35]} {Dmel: FBgn0038837, CG3822, [Score=140, Expect=5e-34]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=253, Expect=2e-76]} {RNA1310_25150} {RNA815_13942} Mlig455_042827 {REF} {Length: 2869} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.9]; Receptor family ligand binding region [PF01094.30, score=49.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.3]; Iron-containing alcohol dehydrogenase [PF13685.8, score=18.6]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=125, Expect=6e-29]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=122, Expect=5e-28]; ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=121, Expect=7e-28]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=120, Expect=2e-27]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=125, Expect=5e-29]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=122, Expect=4e-28]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=121, Expect=1e-27]; ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=120, Expect=1e-27]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=119, Expect=3e-27]} {Dmel: FBgn0039927, CG11155, [Score=127, Expect=7e-30]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=103, Expect=1e-22]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=217, Expect=2e-63]} {RNA1310_25150} {RNA815_13942} Mlig455_063146 {REF} {Length: 2444} {Pfam: Receptor family ligand binding region [PF01094.30, score=35.8]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=82.4, Expect=1e-16]} {RNA1310_25150} {RNA815_13999} |
53. | MligTC455_46881 | 15 | 0.32 | Mlig455_061546 | Neo: - Age: Down-Up-Up |
IAH1 | 2.745 | - | - | 0.999 | 0.795 | 0.951 | - | Mlig455_061546 {REF} {Length: 1647} {Pfam: GDSL-like Lipase/Acylhydrolase family [PF13472.8, score=76.2]; GDSL-like Lipase/Acylhydrolase [PF00657.24, score=32.9]} {Human: ENSG00000134330, IAH1, isoamyl acetate hydrolyzing esterase 1 (putative), [Score=139, Expect=6e-40]} {Mouse: ENSMUSG00000062054, Iah1, isoamyl acetate-hydrolyzing esterase 1 homolog, [Score=122, Expect=1e-33]} {Smed: dd_Smed_v6_6241_0_1, dd_Smed_v6_6241_0_1, [Score=112, Expect=2e-30]} {RNA1310_108127} {RNA815_31492} |
54. | MligTC455_50794 | 32 | 0.67 | Mlig455_026944, Mlig455_027032, Mlig455_027095 | Neo: - Age: - |
2.745 | - | - | 1.000 | - | 0.936 | 0.809 | Mlig455_026944 {REF} {Length: 1102} {Pfam: Lectin C-type domain [PF00059.23, score=41.7]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [RH, Score=73.2, Expect=1e-15]} {RNA1310_33496.1} {RNA815_23317} Mlig455_027032 {REF} {Length: 1107} {Pfam: Lectin C-type domain [PF00059.23, score=45.3]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [RH, Score=72.4, Expect=3e-15]} {RNA1310_33496.1} {RNA815_23317} Mlig455_027095 {REF} {Length: 1081} {Pfam: Lectin C-type domain [PF00059.23, score=43.8]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=66.6, Expect=4e-13]} {RNA1310_33496.1} {RNA815_23317} |
|
55. | MligTC455_50931 | 28 | 0.58 | Mlig455_046985, Mlig455_047028 | Neo: - Age: - |
FCN2 | 2.744 | - | - | 0.971 | - | 0.964 | 0.809 | Mlig455_046985 {REF} {Length: 3620} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=126.1]; PAN domain [PF14295.8, score=27.4]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=22.7]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=2e-15]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=2e-12]} {Dmel: FBgn0031804, CG9500, [Score=79.0, Expect=1e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=59.7, Expect=6e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} Mlig455_047028 {REF} {Length: 1979} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=71.8]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=5e-16]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=8e-13]} {Dmel: FBgn0031804, CG9500, [Score=79.3, Expect=3e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=60.5, Expect=1e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} |
56. | MligTC455_42256 | 163 | 3.39 | Mlig455_054046 | Neo: - Age: Down-Up-Up |
LDB2 | 2.742 | - | - | 0.859 | - | 0.975 | 0.908 | Mlig455_054046 {REF} {Length: 2089} {Pfam: LIM-domain binding protein [PF01803.18, score=164.3]; LIM interaction domain (LID) [PF17916.3, score=55.5]} {Human: ENSG00000169744, LDB2, LIM domain binding 2, [RH, Score=390, Expect=4e-132]} {Mouse: ENSMUSG00000039706, Ldb2, LIM domain binding 2, [RH, Score=388, Expect=3e-131]} {Dmel: FBgn0013764, Chi, Chip, [RH, Score=332, Expect=9e-107]} {Celegans: WBGene00002261, ldb-1, F58A3.1a; LIM Domain Binding protein, [RH, Score=155, Expect=2e-40]} {Smed: dd_Smed_v6_3678_0_1, dd_Smed_v6_3678_0_1, [Score=321, Expect=1e-102]} {RNA1310_27326} {RNA815_22302} |
57. | MligTC455_31933 | 105 | 2.18 | Mlig455_062083 | Neo: - Age: - |
ANGPTL1 | 2.738 | - | - | 0.957 | 0.891 | 0.890 | - | Mlig455_062083 {REF} {Length: 1024} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=156.7]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=135, Expect=7e-36]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=132, Expect=2e-34]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=132, Expect=9e-35]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=137, Expect=1e-36]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=132, Expect=4e-35]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=131, Expect=1e-34]} {Dmel: FBgn0034160, CG5550, [Score=130, Expect=2e-36]} {Celegans: WBGene00020516, T15B7.1, [Score=73.9, Expect=9e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=126, Expect=2e-32]} {RNA1509_14033} {RNA1310_32107.2} {RNA815_17173.3} |
58. | MligTC455_18945 | 41 | 0.86 | Mlig455_031602 | Neo: - Age: - |
2.732 | - | - | 0.987 | - | 0.936 | 0.809 | Mlig455_031602 {REF} {Length: 914} {RNA1310_75361} {RNA815_24378} | |
59. | MligTC455_49451 | 16 | 0.34 | Mlig455_030374 | Neo: - Age: - |
NOX5 | 2.728 | - | - | 0.959 | - | 0.960 | 0.809 | Mlig455_030374 {REF} {Length: 890} {Pfam: EF hand [PF00036.34, score=93.4]; EF-hand domain [PF13405.8, score=86.0]; EF hand [PF13202.8, score=73.1]; EF-hand domain pair [PF13499.8, score=70.3]; EF-hand domain pair [PF13833.8, score=49.3]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=29.0]; EF-hand domain [PF14658.8, score=23.2]; Caleosin related protein [PF05042.15, score=20.4]; EF-hand domain [PF17958.3, score=19.8]} {Human: ENSG00000255346, NOX5, NADPH oxidase 5, [Score=67.4, Expect=2e-13]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.5, Expect=3e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=63.2, Expect=4e-13]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=63.2, Expect=4e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=63.2, Expect=4e-13]} {Dmel: FBgn0033238, azot, ahuizotl, [Score=64.3, Expect=1e-13]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=62.4, Expect=6e-13]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=101, Expect=2e-28]} {RNA1310_74457} |
60. | MligTC455_19887 | 43 | 0.9 | Mlig455_012639, Mlig455_012658 | Neo: - Age: - |
AC243734.1 | 2.725 | - | - | 0.950 | 0.845 | 0.930 | - | Mlig455_012639 {REF} {Length: 2609} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=222.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=213.5]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=270, Expect=7e-83]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=270, Expect=7e-83]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=267, Expect=1e-81]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=271, Expect=2e-83]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=426, Expect=7e-143]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=317, Expect=8e-101]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=311, Expect=7e-99]} {RNA1509_48029} {RNA1310_34222.1} {RNA815_33884} Mlig455_012658 {REF} {Length: 2365} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=183.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=164.1]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=2e-115]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=2e-115]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=4e-116]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=360, Expect=2e-119]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=409, Expect=5e-138]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=335, Expect=5e-110]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=400, Expect=3e-135]} {RNA1509_48029} {RNA1310_34222.1} {RNA815_33884} |
61. | MligTC455_17578 | 447 | 9.32 | Mlig455_010738 | Neo: - Age: Down-Up-Up Region-specific R2: 8.320 Region-enriched R2: 9.793/0.00000 |
2.72 | - | - | 0.989 | - | 0.932 | 0.799 | Mlig455_010738 {REF} {Length: 642} {RNA1509_48297, RNA1509_55742} {RNA1310_84623, RNA1509_48297, RNA1509_55742} {RNA1509_48297, RNA1509_55742, RNA815_45356} | |
62. | MligTC455_14843 | 19 | 0.39 | Mlig455_064713 | Neo: - Age: - |
2.708 | - | - | 0.998 | - | 0.901 | 0.809 | Mlig455_064713 {REF} {Length: 1584} {RNA1310_60383} {RNA815_48502} | |
63. | MligTC455_43715 | 48 | 0.99 | Mlig455_034191 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.969/0.00817 |
2.708 | - | - | 0.952 | - | 0.947 | 0.809 | Mlig455_034191 {REF} {Length: 895} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250} | |
64. | MligTC455_43390 | 28 | 0.59 | Mlig455_064273 | Neo: - Age: Down-Up-Down |
PRKAR2A | 2.7 | - | - | 0.937 | 0.799 | 0.964 | - | Mlig455_064273 {REF} {Length: 2394} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.5]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=296, Expect=8e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=314, Expect=6e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=5e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
65. | MligTC455_15949 | 37 | 0.76 | Mlig455_059880 | Neo: - Age: - |
2.698 | - | - | 0.970 | - | 0.954 | 0.774 | Mlig455_059880 {REF} {Length: 1226} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Dmel: FBgn0031373, CG15358, [Score=52.8, Expect=4e-08]} {RNA1310_120903} | |
66. | MligTC455_15329 | 22 | 0.47 | Mlig455_060498 | Neo: - Age: - |
2.696 | - | - | 0.942 | - | 0.957 | 0.797 | Mlig455_060498 {REF} {Length: 1186} {Pfam: PAN domain [PF00024.28, score=18.9]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=63.9, Expect=4e-12]} {RNA1310_37660} {RNA815_17816.1} | |
67. | MligTC455_48714 | 132 | 2.74 | Mlig455_037041 | Neo: - Age: - Region-enriched R2: 4.531/0.00493 |
2.691 | - | - | 0.972 | 0.812 | 0.907 | - | Mlig455_037041 {REF} {Length: 1099} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} | |
68. | MligTC455_39985 | 28 | 0.58 | Mlig455_022339, Mlig455_022351 | Neo: - Age: - |
2.689 | - | - | 0.984 | 0.896 | - | 0.809 | Mlig455_022339 {REF} {Length: 783} {RNA1509_47318} {RNA1310_125793} {RNA815_2914.1} Mlig455_022351 {REF} {Length: 1105} {Pfam: WSC domain [PF01822.21, score=64.2]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=64.7, Expect=8e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=51.6, Expect=2e-07]} {RNA1310_59980.1} {RNA815_55549} |
|
69. | MligTC455_42427 | 30 | 0.63 | Mlig455_040552, Mlig455_062085 | Neo: - Age: - |
ANGPT1, ANGPTL2 | 2.689 | - | - | 0.927 | - | 0.978 | 0.784 | Mlig455_040552 {REF} {Length: 1447} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=132.5]} {Human: ENSG00000154188, ANGPT1, angiopoietin 1, [Score=108, Expect=3e-26]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=108, Expect=3e-26]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=108, Expect=4e-27]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=104, Expect=8e-25]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=110, Expect=4e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=108, Expect=2e-26]; ENSMUSG00000022309, Angpt1, angiopoietin 1, [Score=108, Expect=3e-26]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=105, Expect=3e-25]} {Dmel: FBgn0030163, CG1791, [Score=94.4, Expect=3e-23]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=90.1, Expect=3e-20]} {RNA1310_118725} Mlig455_062085 {REF} {Length: 1538} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=130.9]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=108, Expect=4e-26]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=108, Expect=5e-27]; ENSG00000154188, ANGPT1, angiopoietin 1, [Score=107, Expect=7e-26]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=105, Expect=2e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=2e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=110, Expect=5e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=108, Expect=2e-26]; ENSMUSG00000022309, Angpt1, angiopoietin 1, [Score=107, Expect=7e-26]} {Dmel: FBgn0030163, CG1791, [Score=93.6, Expect=5e-23]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=89.4, Expect=5e-20]} {RNA1310_118725} |
70. | MligTC455_34498 | 36 | 0.75 | Mlig455_029862 | Neo: - Age: - |
NPLOC4 | 2.687 | - | - | 0.999 | 0.885 | - | 0.803 | Mlig455_029862 {REF} {Length: 1491} {TRANSSPLICED} {Pfam: NPL4 family, putative zinc binding region [PF05020.17, score=77.9]} {Human: ENSG00000182446, NPLOC4, NPL4 homolog, ubiquitin recognition factor, [Score=98.2, Expect=1e-21]} {Mouse: ENSMUSG00000039703, Nploc4, NPL4 homolog, ubiquitin recognition factor, [Score=102, Expect=3e-23]} {Celegans: WBGene00019121, npl-4.2, NPL (Yeast Nuclear Protein Localization) homolog, [Score=54.3, Expect=6e-08]} {Smed: dd_Smed_v6_5277_0_1, dd_Smed_v6_5277_0_1, [Score=102, Expect=1e-23]} {RNA1509_6797} {RNA1310_13992} {RNA815_5567} |
71. | MligTC455_15450 | 19 | 0.39 | Mlig455_006618 | Neo: - Age: - |
2.685 | - | - | 0.997 | 0.879 | - | 0.809 | Mlig455_006618 {REF} {Length: 653} {Pfam: WSC domain [PF01822.21, score=30.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.5, Expect=7e-09]} {RNA1310_35396.1} {RNA815_56551} | |
72. | MligTC455_19552 | 288 | 6 | Mlig455_055936, Mlig455_068188 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.424 Region-specific R2: 6.302 Region-enriched R2: 4.919/0.00633 Regeneration-depleted R4: -5.607 |
2.685 | - | - | 0.938 | - | 0.964 | 0.783 | Mlig455_055936 {REF} {Length: 665} {RNA1310_71052} {RNA815_36745} Mlig455_068188 {REF} {Length: 714} {RNA1310_71052} {RNA815_36745} |
|
73. | MligTC455_44810 | 226 | 4.72 | Mlig455_013293, Mlig455_035940, Mlig455_058406, Mlig455_058409 | Neo: - Age: - Region-specific R2: 6.204 Region-enriched R2: 5.509/0.00501 |
2.685 | - | - | 0.988 | 0.902 | - | 0.795 | Mlig455_013293 {REF} {Length: 1362} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=56.6, Expect=2e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_035940 {REF} {Length: 1652} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_058406 {REF} {Length: 991} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=4e-09]} {RNA1310_28961.1} {RNA815_27532} Mlig455_058409 {REF} {Length: 1311} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} |
|
74. | MligTC455_52482 | 22 | 0.46 | Mlig455_042671 | Neo: - Age: - |
2.685 | - | - | 0.974 | 0.952 | - | 0.759 | Mlig455_042671 {REF} {Length: 2390} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=150.1]} {Smed: dd_Smed_v6_31771_0_1, dd_Smed_v6_31771_0_1, [Score=71.2, Expect=6e-13]} {RNA1310_47540} {RNA815_16144} | |
75. | MligTC455_41540 | 190 | 3.96 | Mlig455_060056 | Neo: - Age: - Region-enriched R2: 6.605/0.00196 |
GLUL | 2.683 | - | - | 0.994 | 0.880 | - | 0.809 | Mlig455_060056 {REF} {Length: 1355} {Pfam: Glutamine synthetase, catalytic domain [PF00120.26, score=57.3]; Glutamine synthetase, beta-Grasp domain [PF03951.21, score=47.5]} {Human: ENSG00000135821, GLUL, glutamate-ammonia ligase, [RH, Score=511, Expect=1e-180]} {Mouse: ENSMUSG00000026473, Glul, glutamate-ammonia ligase (glutamine synthetase), [RH, Score=511, Expect=0.0]} {Dmel: FBgn0001145, Gs2, Glutamine synthetase 2, [RH, Score=511, Expect=0.0]} {Celegans: WBGene00001604, gln-3, Glutamine synthetase, [RH, Score=515, Expect=0.0]} {Smed: dd_Smed_v6_896_0_1, dd_Smed_v6_896_0_1, [RH, Score=545, Expect=0.0]} {RNA1509_47000} {RNA1310_22329.2} {RNA815_4116.6} |
76. | MligTC455_34499 | 65 | 1.36 | Mlig455_025160, Mlig455_063937 | Neo: - Age: - |
2.682 | - | - | 0.999 | 0.877 | - | 0.806 | Mlig455_025160 {REF} {Length: 942} {RNA1310_54940} {RNA815_33690.1} Mlig455_063937 {REF} {Length: 995} {RNA1310_54940} {RNA815_33690.1} |
|
77. | MligTC455_39890 | 162 | 3.37 | Mlig455_047281, Mlig455_047331, Mlig455_069333 | Neo: - Age: - Region-enriched R2: 6.097/0.00148 |
PLSCR1 | 2.682 | - | - | 0.994 | 0.885 | - | 0.803 | Mlig455_047281 {REF} {Length: 1404} {Pfam: Scramblase [PF03803.17, score=248.1]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=225, Expect=4e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=227, Expect=5e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=222, Expect=3e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=223, Expect=6e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=2e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=306, Expect=1e-104]} {RNA1310_29769} {RNA815_41335} Mlig455_047331 {REF} {Length: 1395} {Pfam: Scramblase [PF03803.17, score=248.1]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=225, Expect=4e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=227, Expect=5e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=222, Expect=3e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=223, Expect=6e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=2e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=306, Expect=1e-104]} {RNA1310_29769} {RNA815_41335} Mlig455_069333 {REF} {Length: 1416} {Pfam: Scramblase [PF03803.17, score=248.7]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=226, Expect=1e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=228, Expect=2e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=223, Expect=1e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=224, Expect=2e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=4e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=304, Expect=2e-103]} {RNA1310_29769} {RNA815_41335} |
78. | MligTC455_15948 | 25 | 0.51 | Mlig455_007630 | Neo: - Age: - |
2.681 | - | - | 0.983 | 0.889 | - | 0.809 | Mlig455_007630 {REF} {Length: 1759} {Pfam: WSC domain [PF01822.21, score=54.5]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.4, Expect=2e-07]} {RNA1509_57286} {RNA1310_33352.2} {RNA815_14158.1} | |
79. | MligTC455_31626 | 38 | 0.79 | Mlig455_032857 | Neo: - Age: - |
SLC23A1 | 2.678 | - | - | 0.998 | 0.910 | - | 0.770 | Mlig455_032857 {REF} {Length: 2462} {Pfam: Permease family [PF00860.22, score=281.6]} {Human: ENSG00000170482, SLC23A1, solute carrier family 23 member 1, [Score=400, Expect=4e-132]; ENSG00000089057, SLC23A2, solute carrier family 23 member 2, [Score=380, Expect=1e-123]} {Mouse: ENSMUSG00000029847, Slc23a4, solute carrier family 23 member 4, [Score=421, Expect=4e-140]} {Dmel: FBgn0037807, CG6293, [Score=355, Expect=2e-115]} {Celegans: WBGene00008252, C51E3.6, [RH, Score=250, Expect=1e-75]} {Smed: dd_Smed_v6_9401_0_1, dd_Smed_v6_9401_0_1, [RH, Score=304, Expect=9e-96]} {RNA1509_16219} {RNA1310_39982} {RNA815_42063} |
80. | MligTC455_04786 | 26 | 0.55 | Mlig455_043817, Mlig455_047431 | Neo: - Age: - |
2.676 | - | - | 0.994 | 0.884 | - | 0.798 | Mlig455_043817 {REF} {Length: 319} {NoTransDecoderORF} {RNA1310_64690} Mlig455_047431 {REF} {Length: 2194} {Pfam: Glycine rich protein [PF12810.9, score=25.3]} {RNA1509_16377} {RNA1310_33363.2} {RNA815_25152} |
|
81. | MligTC455_51334 | 326 | 6.78 | Mlig455_011442, Mlig455_061180 | Neo: - |
2.675 | - | - | 0.890 | - | 0.980 | 0.805 | Mlig455_011442 {REF} {Length: 742} {RNA1310_57576.1} {RNA815_29867} Mlig455_061180 {REF} {Length: 769} {RNA1310_57576.1} {RNA815_29867} |
|
82. | MligTC455_11229 | 51 | 1.06 | Mlig455_054212 | Neo: - Age: - |
2.673 | - | - | 0.989 | 0.880 | - | 0.804 | Mlig455_054212 {REF} {Length: 1481} {RNA1310_23944} {RNA815_32018} | |
83. | MligTC455_18683 | 419 | 8.74 | Mlig455_069928 | Neo: - Age: - Region-specific R2: 6.066 Region-enriched R2: 4.921/0.00217 |
2.669 | - | - | 0.990 | 0.876 | - | 0.803 | Mlig455_069928 {REF} {Length: 845} {RNA1509_25826} {RNA1310_42757} {RNA815_23874} | |
84. | MligTC455_40610 | 165 | 3.43 | Mlig455_064484 | Neo: - Age: - Region-enriched R2: 5.617/0.00105 |
2.669 | - | - | 0.970 | 0.890 | - | 0.809 | Mlig455_064484 {REF} {Length: 2931} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=24.9]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=154, Expect=2e-40]} {RNA1509_26568} {RNA1310_9342.1, RNA1509_26568} {RNA1509_26568, RNA815_7018} | |
85. | MligTC455_35701 | 66 | 1.37 | Mlig455_010067, Mlig455_063254, Mlig455_063279 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.716/0.02468 |
2.667 | - | - | 0.998 | 0.874 | - | 0.795 | Mlig455_010067 {REF} {Length: 2624} {Pfam: Polycystin cation channel [PF08016.14, score=46.7]} {RNA1310_62521} Mlig455_063254 {REF} {Length: 2738} {Pfam: Polycystin cation channel [PF08016.14, score=43.3]; Lipopolysaccharide assembly protein A domain [PF06305.13, score=18.4]} {RNA1509_7418} {RNA1310_62521} {RNA815_3659} Mlig455_063279 {REF} {Length: 2677} {Pfam: Polycystin cation channel [PF08016.14, score=46.0]} {RNA1310_62521} |
|
86. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
2.666 | - | - | 0.910 | - | 0.963 | 0.793 | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
87. | MligTC455_12183 | 53 | 1.11 | Mlig455_004166, Mlig455_004190 | Neo: - Age: - Region-enriched R2: 4.930/0.01881 |
2.665 | - | - | 0.965 | - | 0.974 | 0.726 | Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453} Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453} |
|
88. | MligTC455_13171 | 25 | 0.53 | Mlig455_005963, Mlig455_005967 | Neo: - Age: - |
2.665 | - | - | 0.988 | 0.875 | - | 0.802 | Mlig455_005963 {REF} {Length: 2617} {RNA1509_20946} {RNA1310_146331} {RNA815_35450} Mlig455_005967 {REF} {Length: 1405} {Pfam: Lectin C-type domain [PF00059.23, score=20.7]} {RNA1509_20946} {RNA1310_146331} {RNA815_35450} |
|
89. | MligTC455_26255 | 126 | 2.63 | Mlig455_053706 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.424/0.00107 |
FZD5 | 2.663 | - | - | 0.979 | 0.885 | - | 0.799 | Mlig455_053706 {REF} {Length: 3671} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=393.1]; Fz domain [PF01392.24, score=105.2]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [RH, Score=607, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=600, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [RH, Score=562, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [RH, Score=412, Expect=5e-137]} {Smed: dd_Smed_v6_11823_0_1, dd_Smed_v6_11823_0_1, [RH, Score=551, Expect=0.0]} {RNA1509_49831} {RNA1310_28187, RNA1509_49831} {RNA1509_49831, RNA815_16996} |
90. | MligTC455_44809 | 88 | 1.83 | Mlig455_035938 | Neo: - Age: - |
2.662 | - | - | 0.964 | 0.899 | - | 0.799 | Mlig455_035938 {REF} {Length: 1369} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=55.8, Expect=3e-09]} {RNA1310_28961.1} {RNA815_27532} | |
91. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
2.659 | - | - | 0.875 | - | 0.977 | 0.807 | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
92. | MligTC455_29587 | 14 | 0.29 | Mlig455_044070 | Neo: - Age: - |
2.655 | - | - | 0.919 | - | 0.955 | 0.781 | Mlig455_044070 {REF} {Length: 1365} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} | |
93. | MligTC455_39096 | 110 | 2.29 | Mlig455_019781, Mlig455_019803 | Neo: - Age: - |
2.655 | - | - | 0.960 | 0.886 | - | 0.809 | Mlig455_019781 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=65.0]} {RNA1310_34740} {RNA815_15663} Mlig455_019803 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.1]} {RNA1310_34740} {RNA815_15663} |
|
94. | MligTC455_51559 | 43 | 0.89 | Mlig455_002923, Mlig455_002941 | Neo: - Age: - Region-enriched R2: 6.806/0.01463 |
2.653 | - | - | - | 0.880 | 0.967 | 0.806 | Mlig455_002923 {REF} {Length: 1008} {RNA1310_77227} {RNA815_43894} Mlig455_002941 {REF} {Length: 897} {RNA1310_88681} {RNA815_43894} |
|
95. | MligTC455_52232 | 92 | 1.92 | Mlig455_007894, Mlig455_008001 | Neo: - Age: logFC(26M/2M)=0.549 |
2.651 | - | - | 0.954 | 0.891 | - | 0.806 | Mlig455_007894 {REF} {Length: 1500} {RNA1310_22136} {RNA815_18832} Mlig455_008001 {REF} {Length: 1450} {Pfam: PAN domain [PF00024.28, score=18.9]} {RNA1310_22136} {RNA815_18832} |
|
96. | MligTC455_46429 | 48 | 1 | Mlig455_042128 | Neo: - Age: - |
2.65 | - | - | 0.793 | 0.879 | - | 0.978 | Mlig455_042128 {REF} {Length: 1428} {Pfam: F5/8 type C domain [PF00754.27, score=33.1]} {RNA1310_65361} {RNA815_33677} | |
97. | MligTC455_37793 | 353 | 7.36 | Mlig455_066109, Mlig455_068663 | Neo: - Age: Up-Down-Down |
HMCN1 | 2.65 | - | - | 0.989 | 0.859 | - | 0.802 | Mlig455_066109 {REF} {Length: 7924} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=408.1]; Spondin-like TSP1 domain [PF19028.2, score=285.5]; Polycystin cation channel [PF08016.14, score=239.7]; PLAT/LH2 domain [PF01477.25, score=86.7]; Thrombospondin type 1 domain [PF19030.2, score=78.4]; Ion transport protein [PF00520.33, score=42.7]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=360, Expect=8e-99]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=363, Expect=7e-100]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=199, Expect=5e-51]} {Celegans: WBGene00000082, adt-1, ADAMTS family; ADT-1, [RH, Score=306, Expect=4e-84]} {Smed: dd_Smed_v6_13975_0_1, dd_Smed_v6_13975_0_1, [RH, Score=944, Expect=0.0]} {RNA1509_9601} {RNA1310_488} {RNA815_1711} Mlig455_068663 {REF} {Length: 7866} {Pfam: Thrombospondin type 1 domain [PF00090.21, score=423.7]; Spondin-like TSP1 domain [PF19028.2, score=299.7]; Thrombospondin type 1 domain [PF19030.2, score=92.3]; PLAT/LH2 domain [PF01477.25, score=23.1]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=338, Expect=1e-94]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=341, Expect=9e-96]} {Dmel: FBgn0284221, Sema5c, Semaphorin 5c, [Score=189, Expect=2e-48]} {Celegans: WBGene00000082, adt-1, ADAMTS family; ADT-1, [RH, Score=303, Expect=2e-84]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=282, Expect=3e-77]} {RNA1509_9601} {RNA1310_488} {RNA815_1711} |
98. | MligTC455_45351 | 241 | 5.02 | Mlig455_031191 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.622/0.00310 |
2.65 | - | - | 0.975 | - | 0.948 | 0.727 | Mlig455_031191 {REF} {Length: 2855} {Pfam: Srg family chemoreceptor [PF02118.23, score=28.1]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=26.4]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=26.4]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=49.3, Expect=2e-06]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [Score=54.7, Expect=4e-08]} {RNA1509_20184} {RNA1310_32455} {RNA815_38062} | |
99. | MligTC455_53524 | 34 | 0.7 | Mlig455_010882 | Neo: - Age: - Region-enriched R2: 5.283/0.01696 |
2.649 | - | - | 0.993 | - | 0.875 | 0.781 | Mlig455_010882 {REF} {Length: 1818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.7]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=102, Expect=9e-24]} {RNA1310_45713} {RNA815_35716} | |
100. | MligTC455_11633 | 28 | 0.58 | Mlig455_025325 | Neo: - Age: - |
NWD2 | 2.642 | - | - | 0.993 | 0.748 | 0.901 | - | Mlig455_025325 {REF} {Length: 7673} {Pfam: NACHT domain [PF05729.14, score=32.3]; WD domain, G-beta repeat [PF00400.34, score=28.8]; AAA ATPase domain [PF13191.8, score=26.6]} {Human: ENSG00000174145, NWD2, NACHT and WD repeat domain containing 2, [Score=94.4, Expect=2e-18]} {Mouse: ENSMUSG00000048148, Nwd1, NACHT and WD repeat domain containing 1, [Score=99.4, Expect=4e-20]; ENSMUSG00000090061, Nwd2, NACHT and WD repeat domain containing 2, [Score=95.9, Expect=4e-19]} {Dmel: FBgn0038397, CG10185, [Score=145, Expect=2e-34]} {Celegans: WBGene00020254, T05C3.2, [Score=155, Expect=1e-37]} {Smed: dd_Smed_v6_9023_0_1, dd_Smed_v6_9023_0_1, [Score=221, Expect=8e-58]} {RNA1509_55003} {RNA1310_101755} {RNA815_31021.1} |